NCT06832904
- Conditions
- HER2-positive Breast Cancer, Neoadjuvant Therapy, Pyrotinib
- Locations
-
- The First Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, China
Clinical trial condition
Pyrotinib
Explore clinical trials studying Pyrotinib. Study availability and eligibility vary by location and protocol.
2 public trials
1 recruiting study
Pyrotinib trial results
Not Yet Recruiting
The Real World Study of Pyrotinib in the Treatment of Advanced Breast Cancer With HER2 Positive
NCT06495541
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +6 more
- Locations
-
Not specified